Literature DB >> 7794849

Measurement of creatine kinase activity and diagnosis of ectopic pregnancy.

W C Duncan1, V M Sweeting, P Cawood, P J Illingworth.   

Abstract

OBJECTIVE: To investigate whether the measurement of maternal plasma creatine kinase concentration is of clinical value in the diagnosis of tubal ectopic pregnancy.
DESIGN: A retrospective observational study covering a three month period.
SETTING: The gynaecological emergency service of a UK teaching hospital.
SUBJECTS: One hundred and twenty women presenting with clinical suspicion of an ectopic pregnancy such that plasma human chorionic gonadotrophin (hCG) concentration was measured. MAIN OUTCOME MEASURES: Plasma hCG and creatine kinase concentrations were measured. Pregnancies were classified as ectopic pregnancy, complete miscarriage, incomplete miscarriage or ongoing pregnancy. Pregnancies were further classified as uncertain diagnosis if the diagnosis was not clear after initial investigation.
RESULTS: Twenty-one of the patients had an ectopic pregnancy. Diagnosis was classified as uncertain in 48% of pregnancies studied and in 54% of ectopic pregnancies during the study period. The mean plasma creatine kinase was higher in ectopic pregnancies than other pregnancies in the study group (P < 0.01) and remained higher in the subgroup of patients with uncertain diagnosis (P < 0.05) but there were significant overlaps in creatine kinase concentrations in all four clinical groups. When a cut-off point of 45 iu/l is used, the measurement of plasma creatine kinase activity has a sensitivity of 0.57 and a specificity of 0.67 for the diagnosis of ectopic pregnancy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7794849     DOI: 10.1111/j.1471-0528.1995.tb09100.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  7 in total

Review 1.  Biomarkers for ectopic pregnancy and pregnancy of unknown location.

Authors:  Suneeta Senapati; Kurt T Barnhart
Journal:  Fertil Steril       Date:  2013-01-03       Impact factor: 7.329

2.  Maternal serum creatine kinase does not predict tubal pregnancy.

Authors:  S R Lincoln; J R Dockery; C A Long; W A Rock; B D Cowan
Journal:  J Assist Reprod Genet       Date:  1996-10       Impact factor: 3.412

3.  Endometrial cysteine-rich secretory protein 3 is inhibited by human chorionic gonadotrophin, and is increased in the decidua of tubal ectopic pregnancy.

Authors:  A W Horne; W C Duncan; A E King; S Burgess; P C Lourenco; P Cornes; P Ghazal; A R Williams; L Udby; H O D Critchley
Journal:  Mol Hum Reprod       Date:  2009-03-12       Impact factor: 4.025

4.  Creatine phosphokinase, a new marker in diagnosis of tubal ectopic pregnancy; A Systematic Review.

Authors:  Maryam Ghorbani; Afsaneh Keramat; Farideh Mohsenzadeh Ledari
Journal:  Arch Acad Emerg Med       Date:  2020-01-11

5.  Assessment of the diagnostic capability of serum creatine phosphokinase and its isoenzyme in ectopic pregnancy.

Authors:  Attaollah Ghahiri; Aidin Moshreffar; Aida Najafian; Mojdeh Ghasemi; Hatav Ghasemi Tehrani
Journal:  Int J Fertil Steril       Date:  2012-12-17

6.  Evaluation of serum creatine phosphokinase in diagnosis of tubal ectopic pregnancy compared with intrauterine pregnancy and threatened abortion.

Authors:  Maryam Asgharnia; Roya Faraji; Fariba Mirblouk; Zahra Atrkar Roshan; Ayda Parvizi
Journal:  Iran J Reprod Med       Date:  2012-07

Review 7.  Developing a deeper insight into reproductive biomarkers.

Authors:  Braira Wahid; Hamid Bashir; Muhammad Bilal; Khansa Wahid; Aleena Sumrin
Journal:  Clin Exp Reprod Med       Date:  2017-12-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.